XIAP and breast cancer: In contrast to in cardiomyocytes, overexpression of CCN1in human breast cancer MCF-7 cells upregulates XIAP expression to promote chemoresistance to paclitaxel, Adriamycin, and β-lapachone through integrin αvβ3/αvβ5 and NFκB signaling pathway [30].